APA (7th ed.) Citation

MS, H., CG, C., E, E., WA, B., LS, G., P, T., . . . JA, L. (2009). CD20-directed small modular immunopharmaceutical, TRU-015, depletes normal and malignant B cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(8), 2739. https://doi.org/10.1158/1078-0432.CCR-08-1694

Chicago Style (17th ed.) Citation

MS, Hayden-Ledbetter, et al. "CD20-directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 15, no. 8 (2009): 2739. https://doi.org/10.1158/1078-0432.CCR-08-1694.

MLA (9th ed.) Citation

MS, Hayden-Ledbetter, et al. "CD20-directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 15, no. 8, 2009, p. 2739, https://doi.org/10.1158/1078-0432.CCR-08-1694.